Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

Université de Sherbrooke

$41,000.00

Methods for ultrasensitive and quantitative multimodal molecular imaging of vascular inflammation

EF 2023-24

Résumé
Neurodegenerative diseases and dementia affect almost 40% of Canadians aged 65 and above, and over 900,000 Canadians (65% women) could be living with a form of dementia by 2030. Inflammation is as a major contributor to neurodegenerative diseases but gaining information on inflammation in vivo is difficult. The overall goal of the proposed research program is to design, characterize and validate novel imaging agents and methods for the ultrasensitive detection and quantification of cerebrovascular inflammation. These agents will include micron-sized particles of iron oxide as well as immunoliposomes that can specifically target inflamed brain vasculature and be detected by magnetic resonance imaging. The program is divided into two short-term goals. The first goal is to prepare, optimize and test the new agents in relevant cell lines and in small animal models. The second goal is to develop methodologies to enable quantitation of these agents in vivo by imaging. For the larger community, improving inflammation-targeted agents will reduce the cost and variability of these agents. Their in vivo quantification would help understand much better the role of inflammation in several diseases. Finally, success of our program could enable the transfer of the technologies developed herein towards clinical use, including for monitoring therapeutic interventions/delivery using imaging. The program will train graduate students in a highly competitive imaging centre with an history of clinical translation of imaging agents. Beyond the rigorous work and science ethics that they will acquire, trainees will develop their creativity in a truly interdisciplinary environment actively promoting equality, diversity and inclusion.
Programme
Discovery Grants Program - Individual
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
RGPIN-2021-04046
Name nom
Lepage, Martin
Department département
Médecine nucléaire et radiobiologie - Médecine nucléaire et radiobiologie
Organization id
68
Institution établissement
Université de Sherbrooke
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2021
Award amount
41000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1505
Committee name en
Physics
Committee name fr
Physique
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
3114
Research subject group en
Physics
Research subject group fr
Biological and Medical Physics
Research subject en
Physique
Research subject fr
Physique biologique et médicale
Application title
Methods for ultrasensitive and quantitative multimodal molecular imaging of vascular inflammation
Keyword
Contrast agents; Imaging of inflammation; Magnetic resonance imaging; Micro-particles of iron oxyde; Molecular imaging
Application summary
Neurodegenerative diseases and dementia affect almost 40% of Canadians aged 65 and above, and over 900,000 Canadians (65% women) could be living with a form of dementia by 2030. Inflammation is as a major contributor to neurodegenerative diseases but gaining information on inflammation in vivo is difficult. The overall goal of the proposed research program is to design, characterize and validate novel imaging agents and methods for the ultrasensitive detection and quantification of cerebrovascular inflammation. These agents will include micron-sized particles of iron oxide as well as immunoliposomes that can specifically target inflamed brain vasculature and be detected by magnetic resonance imaging. The program is divided into two short-term goals. The first goal is to prepare, optimize and test the new agents in relevant cell lines and in small animal models. The second goal is to develop methodologies to enable quantitation of these agents in vivo by imaging. For the larger community, improving inflammation-targeted agents will reduce the cost and variability of these agents. Their in vivo quantification would help understand much better the role of inflammation in several diseases. Finally, success of our program could enable the transfer of the technologies developed herein towards clinical use, including for monitoring therapeutic interventions/delivery using imaging. The program will train graduate students in a highly competitive imaging centre with an history of clinical translation of imaging agents. Beyond the rigorous work and science ethics that they will acquire, trainees will develop their creativity in a truly interdisciplinary environment actively promoting equality, diversity and inclusion.